Video
29 Oct 2026

Sai Life Sciences interview on site at CPHI Milan 2026

At CPHI-Milan, Tuneer Ghosh, President CMC at Sai Life Sciences, highlights how innovator pharmaceutical companies are increasingly seeking strategic partners that offer end-to-end services across the drug development journey, with India emerging as an important destination as companies diversify their partnerships. He highlights that Sai Life Sciences’ strength lies in its integrated capabilities as a pure-play CRDMO and, importantly, its culture. Shaped by years of working with leading global pharmaceutical companies, this culture reflects a deep understanding of client expectations and ways of working. When clients engage with Sai, they see a reflection of their own values and culture – a connection that strikes a chord with them.

Content provided by our supplier

Sai Life Sciences Limited

  • Country/Region:
    India
  • On CPHI since:
    2015
  • Employees:
    1000 - 4999
Company types
CMO/CDMO
Contract Research Organisation (CRO)

Other Content from Sai Life Sciences Limited (9)